Recommendations on ELISpot assay validation by the GCC.
Bioanalysis
; 14(4): 187-193, 2022 Feb.
Article
en En
| MEDLINE
| ID: mdl-35135309
ABSTRACT
Gene therapy, cell therapy and vaccine research have led to an increased need to perform cellular immunity testing in a regulated environment to ensure the safety and efficacy of these treatments. The most common method for the measurement of cellular immunity has been Enzyme-Linked Immunospot assays. However, there is a lack of regulatory guidance available discussing the recommendations for developing and validating these types of assays. Hence, the Global CRO Council has issued this white paper to provide a consensus on the different validation parameters required to support Enzyme-Linked Immunospot assays and a harmonized and consistent approach to Enzyme-Linked Immunospot validation among contract research organizations.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Bioensayo
/
Terapia Genética
/
Ensayo de Immunospot Ligado a Enzimas
/
Tratamiento Basado en Trasplante de Células y Tejidos
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Bioanalysis
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos